5-Chloro-7-methyl-[1,2,4]triazolo[1,5-f]pyrimidine

Catalog No.: 
ACFRZC439
CAS No.: 
72411-32-6
Molecular Formula: 
C6H5ClN4
Molecular Weight: 
168.59
5-Chloro-7-methyl-[1,2,4]triazolo[1,5-f]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$186.00In stockInquiry
250mg95%$309.00In stockInquiry
500mg95%$515.00In stockInquiry
1g95%$773.00In stockInquiry
5g95%$2318.00InquiryInquiry
10g95%$3863.00InquiryInquiry
25g95%$7725.00InquiryInquiry
50g95%$12360.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-7-methyl-[1,2,4]triazolo[1,5-f]pyrimidine
IUPAC Name5-chloro-7-methyl-[1,2,4]triazolo[1,5-c]pyrimidine
MDL No.MFCD16660866
Molecular FormulaC6H5ClN4
Molecular Weight168.59
SMILESClC1=NC(C)=CC2=NC=NN21
InChI KeyCAITUXQFBMFSFY-UHFFFAOYSA-N
Synonym[1,2,4]Triazolo[1,5-c]pyrimidine, 5-chloro-7-methyl-;5-Chloro-7-methyl-[1,2,4]triazolo[1,5-f]pyrimidine;5-chloro-7-methyl-[1,2,4]triazolo[1,5-c]pyrimidine
CAS No.72411-32-6

Synthetic Route by SureRoute

1. ACFRZC439 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2In Stock
  4. Then
  5. ACFRZC439 route product structure diagram
    ACFRZC43972411-32-6In Stock
Inquiry

2. ACFRZC439 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFRZC439 route product structure diagram
    ACFRZC43972411-32-6In Stock
Inquiry

3. ACFRZC439 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFRZC439 route product structure diagram
    ACFRZC43972411-32-6In Stock
Inquiry

Comments (0)